Lau Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Lau Associates's AMGN Position: Q4 2019 in Review
Lau Associates reduced its Amgen (AMGN) stake by 1.1% in Q4 2019, selling an estimated $7.5K and leaving 3,016 shares worth $727K. The position accounts for 0.36% of the portfolio, ranked #60.
Lau Associates first reported a position in AMGN in Q3 2018 and has held it in 6 quarters since. The position peaked at $805K in Q4 2018. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.
- Lau Associates held 3,016 shares of Amgen worth $727K as of Q4 2019.
- Lau Associates sold 34 Amgen shares in Q4 2019, an estimated $7.5K.
- Amgen made up 0.36% of Lau Associates's portfolio in Q4 2019, its #60 holding.
- Lau Associates first reported a position in Amgen in Q3 2018 and has held it in 6 quarters since.
- Lau Associates's Amgen position peaked at $805K in Q4 2018.
- 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.
Based on Lau Associates's 13F filing for Q4 2019, filed 5 Feb 2020.